Exclusive: Amylin explores sale, hires bankers: sources
NEW YORK (Reuters) - Amylin Pharmaceuticals Inc , which spurned a $3.5 billion takeover bid from Bristol-Myers Squibb Co and is fending off a lawsuit from activist investor Carl Icahn, started reaching out to potential buyers last week, sources familiar with the situation said on Sunday. Amylin, maker of diabetes drugs Byetta and Bydureon, has hired Credit Suisse and Goldman Sachs as its financial advisers and Skadden Arps as its legal adviser, the sources said. Amylin and its advisers declined to comment. ...
Source: news.yahoo.com
No comments:
Post a Comment